James Armitage

Title: Innovations by James Armitage

Introduction

James Armitage is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of medical diagnostics, particularly in the identification and treatment of lymphomas. With a total of two patents to his name, Armitage's work has the potential to improve patient outcomes in oncology.

Latest Patents

Armitage's latest patents focus on methods for identifying, diagnosing, and predicting survival of lymphomas. His inventions utilize gene expression data to provide a more accurate identification and diagnosis of lymphoproliferative disorders. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder based on gene expression patterns. A key component of his work is the Lymph Dx microarray, which is designed to obtain gene expression data from lymphoma samples. This innovative approach allows for the determination of the identity of a particular lymphoma and aids in predicting survival for patients diagnosed with specific lymphomas. Such advancements are crucial for developing tailored therapeutic approaches for individual patients.

Career Highlights

Throughout his career, James Armitage has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Nebraska. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Armitage has collaborated with notable colleagues, including George Wright and Bruce Tan. These partnerships have likely enhanced the scope and impact of his research in the field of oncology.

Conclusion

James Armitage's contributions to the field of lymphoma diagnostics and treatment exemplify the importance of innovation in medicine. His patents and career achievements reflect a commitment to improving patient care through advanced research and technology.